Developer docs
API playgroundTry for free, no card

Search company profiles

KODAI

Full company profile

uuid0024oej

Namestring
KODAI
Legal namestring
株式会社宏大
Websiteurl
kodai-co.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

KODAI Co., Ltd (株式会社宏大) is a Japanese venture enterprise founded in 2015 and headquartered in Yokohama, with a secondary office in Zama. The company develops optical coherence tomography (OCT) technology — specifically its proprietary M-FD-OCT (Medical Fourier-Domain OCT) platform — for both medical and industrial applications. The underlying architecture combines coherent pulse and carrierless spectrum spread communication technology with Bessel beam optics to achieve higher sensitivity and resolution than conventional OCT systems, and includes a "blood-free" vascular imaging mode that does not require blood removal during patient examination. The company complements its core system with an ultra-compact Bessel beam generator developed in 2020.

The technical IP portfolio is international: Patent No. 6762500 covering the tomographic imaging device was filed in July 2018 and registered in Japan in September 2020, with subsequent grants in the United States (2021) and Europe (2023), plus a national-phase application in China. Founder and representative director Hiroshi Ogawa, who holds a master's degree in electrical engineering and antenna systems from Waseda University and a prior career at NEC developing satellite communication equipment, brings approximately 35 prior patents spanning nonlinear compensation circuitry and microwave engineering. The only disclosed institutional relationship is the company's selection into the NEDO STS program in 2016, which provided government-backed R&D support for the OCT platform.

Commercially, KODAI serves two segments. The primary vertical is medical/healthcare, where the M-FD-OCT system targets vascular imaging without blood removal and high-resolution deep tissue observation. A secondary industrial/manufacturing vertical targets non-destructive testing and inline inspection for CFRP composite materials used in semiconductors and batteries. The go-to-market is a direct-sales model executed through the company website (kodai-co.com), downloadable technical PDFs, conference participation (e.g., ICI for all 2020 poster exhibit), and a single contact phone number. No select customers, distribution partners, resellers, or disclosed pricing or revenue figures appear in the source material.

Short descriptiontext

KODAI Co., Ltd is a Yokohama-based Japanese venture founded in 2015 that develops the proprietary M-FD-OCT optical coherence tomography platform for medical vascular imaging and industrial non-destructive testing, serving healthcare providers and advanced-manufacturing inspection customers through direct sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersYokohama, Japan
HQ citystring
Yokohama
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
optical coherence tomography, medical imaging devices, non-destructive testing, OCT imaging systems, biomedical instrumentation
Industry2 codes
1Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography)
CodeHLAHAJABPrimaryYes
2Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear)
CodeHLAKABAEPrimaryNo
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Optical Instruments & Lenses3827
Product category
Medical Imaging Equipment
Social media profiles1 record
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

KODAI researches, develops, manufactures, and sells optical coherence tomography (OCT) systems for medical and industrial applications. Its flagship M-FD-OCT platform uses coherent pulse and carrierless spectrum spread communication technology combined with Bessel beam optics to deliver high-sensitivity, high-resolution deep imaging, including blood-free vascular OCT for medical use and non-destructive inspection for industrial materials such as CFRP composites. The company also offers an ultra-compact Bessel beam generator component that enhances the imaging performance of its OCT system.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

KODAI offers a unified product portfolio centered on the M-FD-OCT system — a high-sensitivity optical coherence tomography platform for medical and industrial applications. The system is complemented by the company's proprietary ultra-compact Bessel beam generator, which enhances the OCT's imaging capabilities by achieving higher sensitivity and resolution for deep tissue/structure observation.

Product and service2 records
1M-FD-OCT (Medical Fourier-Domain Optical Coherence Tomography)
CategoryOCT Imaging Systems
Description

A high-sensitivity, high-resolution optical coherence tomography system for medical and industrial applications. Uses coherent pulse and carrierless spectrum spread communication technology combined with Bessel beam optics to enable deep tissue and deep material observation, including blood-free vascular imaging for clinical use and non-destructive inspection of composites such as CFRP.

2Ultra-compact Bessel Beam Generator (超小型ベッセル・ビーム発生器)
CategoryOCT Optical Components
Description

A super-compact Bessel beam generator component designed to combine with the M-FD-OCT system to achieve higher sensitivity, higher resolution, and clearer deep observation imaging, including in miniaturized OCT platforms.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2016-01-01
Description

NEDO STS (Sensing Technologies for Application) Program adoption in Heisei 28 (2016). Government-backed R&D support for development of OCT technology. This strategic partnership provided funding and institutional support for the company's core technology development.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Japanese swept-source OCT technology and component vendor with products spanning ophthalmic imaging and industrial sensing. Comparable on proprietary OCT light-source technology and dual medical/industrial commercialization, and a relevant Japan-based peer.

TypeRegional player
Description

Japan-based ophthalmic equipment vendor offering OCT and corneal/topography systems used in clinical practice. A relevant Japanese regional peer competing in the same clinical OCT category where KODAI's vascular OCT applications would eventually be sold.

TypeEmerging player
Description

US-based low-cost OCT developer targeting research, dermatology, and emerging point-of-care applications. Comparable as a smaller deep-tech OCT vendor pursuing non-incumbent clinical and industrial use cases with novel, cost-effective architectures.

TypeBroad incumbent
Description

Polish OCT specialist acquired by Canon, producing REVO and Triton OCT devices used in ophthalmology. A direct competitor to OCT-dedicated players like KODAI, now operating within a large incumbent's distribution and capital structure.

TypeEmerging player
Description

US-based developer of OCT systems and components for research, dermatology, and industrial inspection. Comparable as a smaller, technically focused OCT company pursuing non-retinal clinical and industrial use cases, similar in stage and profile to KODAI.

TypeDirect peer
Description

US-based photonics components and instruments vendor with extensive OCT system offerings spanning research, industrial, and clinical research use cases. Most directly comparable on technology architecture and dual medical/industrial NDT positioning.

TypeBroad incumbent
Description

Major ophthalmic imaging and OCT company with TRC-NW and DRI OCT platforms. Comparable as an incumbent clinical imaging player with a much broader product portfolio, providing a benchmark on how scaled OCT businesses grow.

TypeDirect peer
Description

Germany-based specialist in diagnostic imaging for ophthalmology with a leading SPECTRALIS OCT platform. Directly comparable to KODAI as an OCT-dedicated developer targeting clinical imaging use cases, including high-resolution retinal and posterior-segment applications.

TypeBroad incumbent
Description

Global ophthalmic and surgical microscope leader with a major CIRRUS OCT franchise and wide distribution. Less specialized than KODAI in vascular OCT but establishes OCT as a competitive, well-funded incumbent benchmark across both retinal and broader clinical imaging.

TypeRegional player
Description

Japan-based ophthalmic and medical device manufacturer with OCT and diagnostic imaging product lines. Comparable as a Japan-headquartered clinical OCT competitor with established regulatory clearances and Kanto-region distribution reach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

KODAI

Medical Imaging Equipmentkodai-co.com

KODAI Co., Ltd is a Yokohama-based Japanese venture founded in 2015 that develops the proprietary M-FD-OCT optical coherence tomography platform for medical vascular imaging and industrial non-destructive testing, serving healthcare providers and advanced-manufacturing inspection customers through direct sales.

What KODAI does

KODAI Co., Ltd (株式会社宏大) is a Japanese venture enterprise founded in 2015 and headquartered in Yokohama, with a secondary office in Zama. The company develops optical coherence tomography (OCT) technology — specifically its proprietary M-FD-OCT (Medical Fourier-Domain OCT) platform — for both medical and industrial applications. The underlying architecture combines coherent pulse and carrierless spectrum spread communication technology with Bessel beam optics to achieve higher sensitivity and resolution than conventional OCT systems, and includes a "blood-free" vascular imaging mode that does not require blood removal during patient examination. The company complements its core system with an ultra-compact Bessel beam generator developed in 2020.

The technical IP portfolio is international: Patent No. 6762500 covering the tomographic imaging device was filed in July 2018 and registered in Japan in September 2020, with subsequent grants in the United States (2021) and Europe (2023), plus a national-phase application in China. Founder and representative director Hiroshi Ogawa, who holds a master's degree in electrical engineering and antenna systems from Waseda University and a prior career at NEC developing satellite communication equipment, brings approximately 35 prior patents spanning nonlinear compensation circuitry and microwave engineering. The only disclosed institutional relationship is the company's selection into the NEDO STS program in 2016, which provided government-backed R&D support for the OCT platform.

Commercially, KODAI serves two segments. The primary vertical is medical/healthcare, where the M-FD-OCT system targets vascular imaging without blood removal and high-resolution deep tissue observation. A secondary industrial/manufacturing vertical targets non-destructive testing and inline inspection for CFRP composite materials used in semiconductors and batteries. The go-to-market is a direct-sales model executed through the company website (kodai-co.com), downloadable technical PDFs, conference participation (e.g., ICI for all 2020 poster exhibit), and a single contact phone number. No select customers, distribution partners, resellers, or disclosed pricing or revenue figures appear in the source material.

KODAI firmographics

Firmographics
Name
KODAI
Legal name
株式会社宏大
Website
https://kodai-co.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
KODAI Co., Ltd is a Yokohama-based Japanese venture founded in 2015 that develops the proprietary M-FD-OCT optical coherence tomography platform for medical vascular imaging and industrial non-destructive testing, serving healthcare providers and advanced-manufacturing inspection customers through direct sales.
Ownership category
akta.pro rank

KODAI industry classification

Industry
Product category
Medical Imaging Equipment
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
Optical Instruments & Lenses (3827)
akta.pro primary industry
Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography) (HLAHAJAB)
akta.pro secondary industry
Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE)

Keywords

  • Optical coherence tomography
  • Medical imaging devices
  • Non-destructive testing
  • OCT imaging systems
  • Biomedical instrumentation

Where KODAI is headquartered

Location

Headquarters

HQ city
Yokohama
HQ country
Japan
HQ region
Asia

Offices2 records

Markets served

KODAI business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Distribution channels1 record

Marketing channels3 records

KODAI product offering

Product offering

Core offering

KODAI researches, develops, manufactures, and sells optical coherence tomography (OCT) systems for medical and industrial applications. Its flagship M-FD-OCT platform uses coherent pulse and carrierless spectrum spread communication technology combined with Bessel beam optics to deliver high-sensitivity, high-resolution deep imaging, including blood-free vascular OCT for medical use and non-destructive inspection for industrial materials such as CFRP composites. The company also offers an ultra-compact Bessel beam generator component that enhances the imaging performance of its OCT system.

Product overview

KODAI offers a unified product portfolio centered on the M-FD-OCT system — a high-sensitivity optical coherence tomography platform for medical and industrial applications. The system is complemented by the company's proprietary ultra-compact Bessel beam generator, which enhances the OCT's imaging capabilities by achieving higher sensitivity and resolution for deep tissue/structure observation.

Differentiator

Problem solved

Functional benefit

Products and services

  • M-FD-OCT (Medical Fourier-Domain Optical Coherence Tomography) A high-sensitivity, high-resolution optical coherence tomography system for medical and industrial applications. Uses coherent pulse and carrierless spectrum spread communication technology combined with Bessel beam optics to enable deep tissue and deep material observation, including blood-free vascular imaging for clinical use and non-destructive inspection of composites such as CFRP.
  • Ultra-compact Bessel Beam Generator (超小型ベッセル・ビーム発生器) A super-compact Bessel beam generator component designed to combine with the M-FD-OCT system to achieve higher sensitivity, higher resolution, and clearer deep observation imaging, including in miniaturized OCT platforms.

Companies that use KODAI

Customer profile

Segments2 records

Ideal customer profiles2 records

KODAI technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

KODAI partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • NEDO (New Energy and Industrial Technology Development Organization)coreStrategic or Co-development Partner · 1 January 2016NEDO STS (Sensing Technologies for Application) Program adoption in Heisei 28 (2016). Government-backed R&D support for development of OCT technology. This strategic partnership provided funding and institutional support for the company's core technology development.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

KODAI competitors and assessment

Company assessment

Direct peers

  • Santec: Japanese swept-source OCT technology and component vendor with products spanning ophthalmic imaging and industrial sensing. Comparable on proprietary OCT light-source technology and dual medical/industrial commercialization, and a relevant Japan-based peer.
  • Thorlabs: US-based photonics components and instruments vendor with extensive OCT system offerings spanning research, industrial, and clinical research use cases. Most directly comparable on technology architecture and dual medical/industrial NDT positioning.
  • Heidelberg Engineering: Germany-based specialist in diagnostic imaging for ophthalmology with a leading SPECTRALIS OCT platform. Directly comparable to KODAI as an OCT-dedicated developer targeting clinical imaging use cases, including high-resolution retinal and posterior-segment applications.

Regional players

  • Tomey Corporation: Japan-based ophthalmic equipment vendor offering OCT and corneal/topography systems used in clinical practice. A relevant Japanese regional peer competing in the same clinical OCT category where KODAI's vascular OCT applications would eventually be sold.
  • NIDEK: Japan-based ophthalmic and medical device manufacturer with OCT and diagnostic imaging product lines. Comparable as a Japan-headquartered clinical OCT competitor with established regulatory clearances and Kanto-region distribution reach.

Emerging players

  • Optores (Wasatch/German spin cohort) / Lumedica-OQ Imaging: US-based low-cost OCT developer targeting research, dermatology, and emerging point-of-care applications. Comparable as a smaller deep-tech OCT vendor pursuing non-incumbent clinical and industrial use cases with novel, cost-effective architectures.
  • Wasatch Photonics: US-based developer of OCT systems and components for research, dermatology, and industrial inspection. Comparable as a smaller, technically focused OCT company pursuing non-retinal clinical and industrial use cases, similar in stage and profile to KODAI.

Broad incumbents

  • Optopol Technology (Canon): Polish OCT specialist acquired by Canon, producing REVO and Triton OCT devices used in ophthalmology. A direct competitor to OCT-dedicated players like KODAI, now operating within a large incumbent's distribution and capital structure.
  • Topcon Healthcare: Major ophthalmic imaging and OCT company with TRC-NW and DRI OCT platforms. Comparable as an incumbent clinical imaging player with a much broader product portfolio, providing a benchmark on how scaled OCT businesses grow.
  • Carl Zeiss Meditec: Global ophthalmic and surgical microscope leader with a major CIRRUS OCT franchise and wide distribution. Less specialized than KODAI in vascular OCT but establishes OCT as a competitive, well-funded incumbent benchmark across both retinal and broader clinical imaging.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

KODAI social profiles

Digital presence

KODAI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

KODAI leadership team

Management profile

Number of profiles

Profiles1 record

KODAI funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

KODAI M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KODAI

What does KODAI do?

KODAI researches, develops, manufactures, and sells optical coherence tomography (OCT) systems for medical and industrial applications. Its flagship M-FD-OCT platform uses coherent pulse and carrierless spectrum spread communication technology combined with Bessel beam optics to deliver high-sensitivity, high-resolution deep imaging, including blood-free vascular OCT for medical use and non-destructive inspection for industrial materials such as CFRP composites. The company also offers an ultra-compact Bessel beam generator component that enhances the imaging performance of its OCT system.

Is KODAI a public or private company?

KODAI is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was KODAI founded?

KODAI was founded in 2015. It employs 1 to 10 people.

Where is KODAI based?

KODAI is headquartered in Yokohama, Japan, in the Asia region.

Who are KODAI's main competitors?

Direct peers on record are Santec, Thorlabs and Heidelberg Engineering. Regional players are Tomey Corporation and NIDEK. Emerging players are Optores (Wasatch/German spin cohort) / Lumedica-OQ Imaging and Wasatch Photonics. Broad incumbents are Optopol Technology (Canon), Topcon Healthcare and Carl Zeiss Meditec.

Does KODAI have an API?

No public API is recorded for KODAI.

What industry is KODAI in?

KODAI's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHAJAB, Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography), with a secondary code of HLAKABAE, Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear). Its NAICS code is 339112 and its SIC code is 3827.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales